The Foundation of the National Lipid Association Announces Research Abstract Award Winners

Last Updated: Saturday, 18-May-2019 17:30:00 EDT

MIAMI, Fla. – (May 18, 2019) -- Clinical lipidology’s best and brightest up-and-comers have been singled out for their exceptional abstracts at the National Lipid Association’s (NLA) 2019 Scientific Sessions, taking place May 16 – 19 in Miami.

Five Young Investigator Abstract Award Winners were selected from those engaged in innovative research work in the field of clinical lipidology and cardiovascular disease prevention. The competition is open to in-training students, residents, fellows and NLA members in practice for five years or less.

Here’s a look at authors chosen as Young Investigator Abstract Award Winners for their exceptional work:

First Place:                  Brian Cheung, MD, Internal Medicine Resident, St. Bernards® Medical Center, Jonesboro, AR, “Severe Combined Hyperlipidemia, Heterozygous APOE p.V254E, Pancreatitis, Diabetes 

                                     Mellitus, and Plantar Xanthomas” (Abstract 308)* *Dr. Cheung will be presenting his award-winning abstract on Saturday, May 18, from 2:40 to 2:50 p.m. during the NLA’s Scientific Sessions.

Second Place:             Liam R. Brunham, MD, PhD - Vancouver General Hospital, Ontario, Canada, “Impact of Monogenic Familial Hypercholesterolemia and Polygenic Hypercholesterolemia

Cardiovascular                                                   Disease Risk” (Abstract 267)

Third Place:                Hammad Ur Rahman, MD – Guthrie Robert Packer Hospital, Sayre, PA, “Effects of Marine Omega-3 Fatty Acids On Cardiovascular Outcomes in Patients with Ischemic Heart Disease: A 

                                    Meta-Analysis” (Abstract 310)

Fourth Place:              Qian Ye, MD – Internist, Mayo Clinic, Rochester, MN, “Cognitive Function in Patients on Evolocumab” (Abstract 306)

Fifth Place:                 Michael Wesley Milks, MD, FACC – Assistant Professor of Clinical Medicine at University Wexner Medical Center, Ohio State University, Columbus, OH

                                    “Real-World Health Care Costs Incurred by Early Adopters of PCSK9 Inhibitor Therapy” (Abstract 344)


Also singled out for recognition was Emily Brown, MS, MGC, Genetic Counselor with the JohnsHopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, MD. She is

 the recipient of the Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award for her paper entitled, “Incorporation of Genetic Testing for Familial

Hypercholesterolemia Nearly Doubles Diagnosis Rate(Abstract #280)*.


An inherited condition, FH causes a defect in the body’s ability to remove excess low-density lipoprotein (LDL or bad) cholesterol from the blood. Over time, the elevated blood cholesterol

can lead to blockages in the arteries of the heart and/or brain of the FH patient (including children).

*Brown will be presenting her award-winning abstract on Saturday, May 18, from 3:10 to 3:20 p.m. during the NLA’s Scientific Sessions.


These awards are supported by donations from Amgen Inc.